Finding markers to track menopause in women
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks for biological signs that can help monitor menopause. It may help women understand their menopause transition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a biological female age 20 or older.
- You do not have cancer.
- You do not have any active or long-term infection.
- You are not pregnant, gave birth within the last year, or breastfeeding within the last 3 months.
- You are not on any female hormone therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how menopause affects heart health in women. It aims to find ways to help women stay healthy during this transition.
This study tracks the health of women aged 35 to 65 going through menopause. It aims to better understand common health issues and improve care.
This study follows people through menopause to better understand how the body changes and how that may affect heart health risk. You may be asked for health checks over time, as researchers look for factors that increase or protect against heart problems.
This study looks at how bone health changes in women with premature ovarian insufficiency (early menopause). It aims to understand the body's bone metabolism to help manage long-term health.
This study collects health information from women going through perimenopause (transition to menopause), menopause, early menopause, or premature ovarian insufficiency (POI—early loss of ovarian function). Researchers use this data to better understand these conditions and improve care.
This study uses a wearable device and your iPhone to track changes in your body as you approach or go through menopause. Researchers hope to better understand this transition and help improve how people experience it.
Hear when a new Perimenopausal Biomarkers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.